4.82
Precedente Chiudi:
$4.09
Aprire:
$4.08
Volume 24 ore:
2.36M
Relative Volume:
1.50
Capitalizzazione di mercato:
$127.74M
Reddito:
-
Utile/perdita netta:
$-30.26M
Rapporto P/E:
-2.3627
EPS:
-2.04
Flusso di cassa netto:
$-24.69M
1 W Prestazione:
+43.03%
1M Prestazione:
+135.12%
6M Prestazione:
+143.43%
1 anno Prestazione:
-31.82%
Annovis Bio Inc Stock (ANVS) Company Profile
Nome
Annovis Bio Inc
Settore
Industria
Telefono
484-875-3192
Indirizzo
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Confronta ANVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ANVS
Annovis Bio Inc
|
4.82 | 108.40M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Downgrade | D. Boral Capital | Buy → Hold |
| 2024-10-25 | Aggiornamento | Maxim Group | Hold → Buy |
| 2023-12-29 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
Annovis Bio Inc Borsa (ANVS) Ultime notizie
Alzheimer's Disease Market to Evolve Rapidly Over the Next - openPR.com
Annovis Bio director Hoffman buys $159k in shares - Investing.com
Parkinson’s Breakthrough? New Data Shows Drug May Reverse Cognitive Decline - MyChesCo
Annovis Announces Two Presentations at the CTAD 2025 Conference - The Manila Times
Annovis Bio director Hoffman buys $69.9k in ANVS stock By Investing.com - Investing.com Nigeria
Annovis Bio director Hoffman buys $69.9k in ANVS stock - Investing.com
Will Annovis Bio Inc. stock attract long term capital inflows2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
How Annovis Bio Inc. stock reacts to stronger dollarJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Annovis Bio Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - earlytimes.in
How Annovis Bio Inc. stock reacts to monetary easingTake Profit & Verified Momentum Watchlists - newser.com
Why Annovis Bio Inc. stock fits value portfoliosWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Can Annovis Bio Inc. stock deliver sustainable ROEWeekly Stock Report & Daily Volume Surge Trade Alerts - newser.com
Will Annovis Bio Inc. stock benefit from automationJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
Will Annovis Bio Inc. stock outperform Dow JonesShare Buyback & Detailed Earnings Play Alerts - newser.com
Why Annovis Bio Inc. stock is a must watch tickerShare Buyback & Scalable Portfolio Growth Ideas - newser.com
How Annovis Bio Inc. stock compares with market leadersJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Is Annovis Bio Inc. stock attractive for passive investors2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
How Annovis Bio Inc. stock compares with top peers2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
Annovis Stock Rises After Company Confirms Meeting With Regulators To Discuss Drug In Treating Parkinson's Disease Dementia - MSN
Can momentum traders help lift Annovis Bio Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com
FDA to hear plan for buntanetap as Parkinson’s dementia treatment - Parkinson's News Today
What does recent volatility data suggest for Annovis Bio Inc.July 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Annovis Bio Inc. stock volume spike explainedJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Can Annovis Bio Inc. stock deliver consistent EPS growth2025 Price Action Summary & Intraday High Probability Setup Alerts - newser.com
Applying Wyckoff theory to Annovis Bio Inc. stockJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise - MyChesCo
Why retail traders accumulate Annovis Bio Inc. stockQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com
How geopolitical risks impact Annovis Bio Inc. stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Annovis Bio Inc Azioni (ANVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):